In the last 12 months, insiders at EXACT SCIENCES CORP ($EXAS) filed 462 transactions with the SEC: 1 open-market purchases totaling $1,001,325 and 62 sales totaling $8,534,388. Net insider sentiment: net selling.
EXACT SCIENCES CORP operates in the Services-medical laboratories industry (Industrial Applications and Services sector).
Most Active Insiders
- Conroy Kevin T (President and CEO) — 79 transactions totaling $53,203,725
- Baranick Brian (EVP, GM, Precision Oncology) — 51 transactions totaling $9,602,562
- ORVILLE JACOB A (EVP, GM, Screening) — 47 transactions totaling $7,940,016
- Condella Sarah (EVP, Human Resources) — 66 transactions totaling $5,834,292
- Herriott James (SVP, General Counsel & Sec) — 52 transactions totaling $5,614,274
View all SEC Filings for EXACT SCIENCES CORP (EXAS).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 23, 2026 | Herriott James | SVP, General Counsel & Sec | D | Common Stock | 1762 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | Conroy Kevin T | President and CEO | D | Common Stock | 29061 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.02% |
| March 23, 2026 | Conroy Kevin T | President and CEO | D | Common Stock | 1397738 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.73% |
| March 23, 2026 | Conroy Kevin T | President and CEO | A | Common Stock | 119312 | $0.00 | 1,397,738.0000 | 190,888,211 | 9.33% | 0.06% |
| March 23, 2026 | Condella Sarah | EVP, Human Resources | D | Restricted Stock Units | 23224 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.01% |
| March 23, 2026 | Condella Sarah | EVP, Human Resources | D | Stock Options (Right to Buy) | 6581 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | Condella Sarah | EVP, Human Resources | D | Stock Options (Right to Buy) | 7790 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | Condella Sarah | EVP, Human Resources | D | Stock Options (Right to Buy) | 11700 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.01% |
| March 23, 2026 | Condella Sarah | EVP, Human Resources | D | Stock Options (Right to Buy) | 21948 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.01% |
| March 23, 2026 | Condella Sarah | EVP, Human Resources | D | Common Stock | 6368 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | Condella Sarah | EVP, Human Resources | D | Common Stock | 191891 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.10% |
| March 23, 2026 | Condella Sarah | EVP, Human Resources | A | Common Stock | 60389 | $0.00 | 191,891.0000 | 190,888,211 | 45.92% | 0.03% |
| March 23, 2026 | Bloomer Aaron | EVP, Chief Financial Officer | D | Restricted Stock Units | 28063 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.01% |
| March 23, 2026 | Bloomer Aaron | EVP, Chief Financial Officer | D | Restricted Stock Units | 4395 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | Bloomer Aaron | EVP, Chief Financial Officer | D | Common Stock | 417 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | Bloomer Aaron | EVP, Chief Financial Officer | D | Common Stock | 138679 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.07% |
| March 23, 2026 | Bloomer Aaron | EVP, Chief Financial Officer | A | Common Stock | 89911 | $0.00 | 138,679.0000 | 190,888,211 | 184.36% | 0.05% |
| March 23, 2026 | Herriott James | SVP, General Counsel & Sec | D | Restricted Stock Units | 20321 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.01% |
| March 23, 2026 | Herriott James | SVP, General Counsel & Sec | D | Stock Options (Right to Buy) | 2861 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | Herriott James | SVP, General Counsel & Sec | D | Stock Options (Right to Buy) | 793 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | COWARD D SCOTT | Not found | D | Stock Options (Right to Buy) | 4175 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | COWARD D SCOTT | Not found | D | Stock Options (Right to Buy) | 10786 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.01% |
| March 23, 2026 | COWARD D SCOTT | Not found | D | Stock Options (Right to Buy) | 12875 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.01% |
| March 23, 2026 | Petrovic Shacey | Not found | D | Common Stock | 16406 | $0.00 | 5,398.0000 | 190,888,211 | 75.24% | 0.01% |
| March 23, 2026 | Petrovic Shacey | Not found | D | Common Stock | 5398 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | Petrovic Shacey | Not found | D | Common Stock | 7095 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | Zanotti Katherine S | Not found | D | Common Stock | 55361 | $0.00 | 5,398.0000 | 190,888,211 | 91.12% | 0.03% |
| March 23, 2026 | Zanotti Katherine S | Not found | D | Common Stock | 5398 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | Popovits Kimberly J | Not found | D | Common Stock | 6725 | $0.00 | 9,656.0000 | 190,888,211 | 41.05% | 0.00% |
| March 23, 2026 | Popovits Kimberly J | Not found | D | Common Stock | 9656 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.01% |
| March 23, 2026 | Doyle James Edward | Not found | D | Common Stock | 52564 | $0.00 | 5,398.0000 | 190,888,211 | 90.69% | 0.03% |
| March 23, 2026 | Doyle James Edward | Not found | D | Common Stock | 5398 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | Clancy Paul J | Not found | D | Common Stock | 20640 | $0.00 | 5,398.0000 | 190,888,211 | 79.27% | 0.01% |
| March 23, 2026 | Clancy Paul J | Not found | D | Common Stock | 5398 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | Barber Michael J | Not found | D | Common Stock | 7738 | $0.00 | 5,398.0000 | 190,888,211 | 58.91% | 0.00% |
| March 23, 2026 | Barber Michael J | Not found | D | Common Stock | 5398 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | Barber Michael J | Not found | D | Deferred Stock Units | 7422 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | Trigg Leslie | Not found | D | Common Stock | 3244 | $0.00 | 13,925.0000 | 190,888,211 | 18.89% | 0.00% |
| March 23, 2026 | Trigg Leslie | Not found | D | Common Stock | 13925 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.01% |
| March 23, 2026 | Conroy Kevin T | President and CEO | D | Common Stock | 46538 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.02% |
| March 23, 2026 | Herriott James | SVP, General Counsel & Sec | D | Common Stock | 68195 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.04% |
| March 23, 2026 | Baranick Brian | EVP, GM, Precision Oncology | D | Restricted Stock Units | 28063 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.01% |
| March 23, 2026 | Baranick Brian | EVP, GM, Precision Oncology | D | Common Stock | 795 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | Baranick Brian | EVP, GM, Precision Oncology | D | Common Stock | 137195 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.07% |
| March 23, 2026 | Baranick Brian | EVP, GM, Precision Oncology | A | Common Stock | 33321 | $0.00 | 137,195.0000 | 190,888,211 | 32.08% | 0.02% |
| March 23, 2026 | Conroy Kevin T | President and CEO | D | Common Stock | 86750 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.05% |
| March 23, 2026 | Conroy Kevin T | President and CEO | D | Common Stock | 117427 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.06% |
| March 23, 2026 | Conroy Kevin T | President and CEO | D | Stock Options (Right to Buy) | 235388 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.12% |
| March 23, 2026 | Conroy Kevin T | President and CEO | D | Stock Options (Right to Buy) | 66047 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.03% |
| March 23, 2026 | Conroy Kevin T | President and CEO | D | Stock Options (Right to Buy) | 34110 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.02% |
| March 23, 2026 | Conroy Kevin T | President and CEO | D | Stock Options (Right to Buy) | 100916 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.05% |
| March 23, 2026 | Conroy Kevin T | President and CEO | D | Restricted Stock Units | 18143 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.01% |
| March 23, 2026 | Conroy Kevin T | President and CEO | D | Restricted Stock Units | 44336 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.02% |
| March 23, 2026 | Conroy Kevin T | President and CEO | D | Restricted Stock Units | 83360 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.04% |
| March 23, 2026 | Conroy Kevin T | President and CEO | D | Restricted Stock Units | 154829 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.08% |
| March 23, 2026 | ORVILLE JACOB A | EVP, GM, Screening | A | Common Stock | 53323 | $0.00 | 153,726.0000 | 190,888,211 | 53.11% | 0.03% |
| March 23, 2026 | ORVILLE JACOB A | EVP, GM, Screening | D | Common Stock | 153726 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.08% |
| March 23, 2026 | ORVILLE JACOB A | EVP, GM, Screening | D | Common Stock | 1774 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | ORVILLE JACOB A | EVP, GM, Screening | D | Stock Options (Right to Buy) | 6581 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | ORVILLE JACOB A | EVP, GM, Screening | D | Restricted Stock Units | 38707 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.02% |
| March 23, 2026 | COWARD D SCOTT | Not found | D | Common Stock | 52164 | $0.00 | 5,398.0000 | 190,888,211 | 90.62% | 0.03% |
| March 23, 2026 | COWARD D SCOTT | Not found | D | Common Stock | 5398 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | COWARD D SCOTT | Not found | D | Common Stock | 4694 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| Feb. 27, 2026 | Conroy Kevin T | President and CEO | M | Common Stock | 18143 | $0.00 | 1,539,874.0000 | 190,888,211 | 1.19% | 0.01% |
| Feb. 27, 2026 | Conroy Kevin T | President and CEO | M | Restricted Stock Units | 27786 | $0.00 | 83,360.0000 | 190,888,211 | 25.00% | 0.01% |
| Feb. 27, 2026 | Conroy Kevin T | President and CEO | M | Restricted Stock Units | 22168 | $0.00 | 44,336.0000 | 190,888,211 | 33.33% | 0.01% |
| Feb. 27, 2026 | Conroy Kevin T | President and CEO | M | Restricted Stock Units | 18143 | $0.00 | 18,143.0000 | 190,888,211 | 50.00% | 0.01% |
| Feb. 27, 2026 | Conroy Kevin T | President and CEO | F | Common Stock | 13060 | $103.25 | 1,557,821.0000 | 190,888,211 | 0.83% | 0.01% |
| Feb. 27, 2026 | Conroy Kevin T | President and CEO | M | Common Stock | 27786 | $0.00 | 1,570,881.0000 | 190,888,211 | 1.80% | 0.01% |
| Feb. 27, 2026 | Conroy Kevin T | President and CEO | F | Common Stock | 10419 | $103.25 | 1,543,095.0000 | 190,888,211 | 0.67% | 0.01% |
| Feb. 27, 2026 | Conroy Kevin T | President and CEO | M | Common Stock | 22168 | $0.00 | 1,553,514.0000 | 190,888,211 | 1.45% | 0.01% |
| Feb. 27, 2026 | Conroy Kevin T | President and CEO | F | Common Stock | 8528 | $103.25 | 1,531,346.0000 | 190,888,211 | 0.55% | 0.00% |
| Feb. 27, 2026 | Condella Sarah | EVP, Human Resources | M | Stock Options (Right to Buy) | 3900 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| Feb. 27, 2026 | Condella Sarah | EVP, Human Resources | F | Common Stock | 1913 | $103.38 | 137,489.0000 | 190,888,211 | 1.37% | 0.00% |
| Feb. 27, 2026 | Condella Sarah | EVP, Human Resources | M | Common Stock | 3900 | $5.03 | 139,402.0000 | 190,888,211 | 2.88% | 0.00% |
| Feb. 25, 2026 | Bloomer Aaron | EVP, Chief Financial Officer | A | Restricted Stock Units | 28063 | $0.00 | 28,063.0000 | 190,888,211 | 9999.99% | 0.01% |
| Feb. 25, 2026 | ORVILLE JACOB A | EVP, GM, Screening | A | Restricted Stock Units | 38707 | $0.00 | 38,707.0000 | 190,888,211 | 9999.99% | 0.02% |
| Feb. 25, 2026 | Baranick Brian | EVP, GM, Precision Oncology | A | Restricted Stock Units | 28063 | $0.00 | 28,063.0000 | 190,888,211 | 9999.99% | 0.01% |
| Feb. 25, 2026 | Conroy Kevin T | President and CEO | A | Restricted Stock Units | 154829 | $0.00 | 154,829.0000 | 190,888,211 | 9999.99% | 0.08% |
| Feb. 25, 2026 | Conroy Kevin T | President and CEO | F | Common Stock | 6196 | $103.45 | 1,521,721.0000 | 190,888,211 | 0.41% | 0.00% |
| Feb. 25, 2026 | Condella Sarah | EVP, Human Resources | A | Restricted Stock Units | 23224 | $0.00 | 23,224.0000 | 190,888,211 | 9999.99% | 0.01% |
| Feb. 25, 2026 | Herriott James | SVP, General Counsel & Sec | A | Restricted Stock Units | 20321 | $0.00 | 20,321.0000 | 190,888,211 | 9999.99% | 0.01% |
| Feb. 25, 2026 | Conroy Kevin T | President and CEO | A | Common Stock | 13181 | $0.00 | 1,527,917.0000 | 190,888,211 | 0.87% | 0.01% |
| Dec. 23, 2025 | Condella Sarah | EVP, Human Resources | M | Common Stock | 3955 | $0.00 | 91,901.0000 | 189,471,298 | 4.50% | 0.00% |
| Dec. 23, 2025 | Baranick Brian | EVP, GM, Precision Oncology | M | Restricted Stock Units | 16051 | $0.00 | 0.0000 | 189,471,298 | 100.00% | 0.01% |
| Dec. 23, 2025 | Baranick Brian | EVP, GM, Precision Oncology | M | Restricted Stock Units | 28779 | $0.00 | 0.0000 | 189,471,298 | 100.00% | 0.02% |
| Dec. 23, 2025 | Baranick Brian | EVP, GM, Precision Oncology | M | Restricted Stock Units | 14845 | $0.00 | 0.0000 | 189,471,298 | 100.00% | 0.01% |
| Dec. 23, 2025 | Baranick Brian | EVP, GM, Precision Oncology | M | Restricted Stock Units | 9450 | $0.00 | 0.0000 | 189,471,298 | 100.00% | 0.00% |
| Dec. 23, 2025 | Baranick Brian | EVP, GM, Precision Oncology | M | Restricted Stock Units | 3955 | $0.00 | 0.0000 | 189,471,298 | 100.00% | 0.00% |
| Dec. 24, 2025 | Baranick Brian | EVP, GM, Precision Oncology | F | Common Stock | 14938 | $101.59 | 104,544.0000 | 189,471,298 | 12.50% | 0.01% |
| Dec. 24, 2025 | Baranick Brian | EVP, GM, Precision Oncology | A | Common Stock | 29416 | $0.00 | 119,482.0000 | 189,471,298 | 32.66% | 0.02% |
| Dec. 23, 2025 | Baranick Brian | EVP, GM, Precision Oncology | F | Common Stock | 10453 | $101.82 | 90,066.0000 | 189,471,298 | 10.40% | 0.01% |
| Dec. 23, 2025 | Baranick Brian | EVP, GM, Precision Oncology | A | Common Stock | 20584 | $0.00 | 100,519.0000 | 189,471,298 | 25.75% | 0.01% |
| Dec. 23, 2025 | Baranick Brian | EVP, GM, Precision Oncology | F | Common Stock | 21594 | $101.82 | 79,935.0000 | 189,471,298 | 21.27% | 0.01% |
| Dec. 23, 2025 | Baranick Brian | EVP, GM, Precision Oncology | A | Common Stock | 42523 | $0.00 | 101,529.0000 | 189,471,298 | 72.07% | 0.02% |
| Dec. 23, 2025 | Baranick Brian | EVP, GM, Precision Oncology | F | Common Stock | 8151 | $101.82 | 59,006.0000 | 189,471,298 | 12.14% | 0.00% |
| Dec. 23, 2025 | Baranick Brian | EVP, GM, Precision Oncology | M | Common Stock | 16051 | $0.00 | 67,157.0000 | 189,471,298 | 31.41% | 0.01% |
| Dec. 23, 2025 | Baranick Brian | EVP, GM, Precision Oncology | F | Common Stock | 14614 | $101.82 | 51,106.0000 | 189,471,298 | 22.24% | 0.01% |
| Dec. 23, 2025 | Baranick Brian | EVP, GM, Precision Oncology | M | Common Stock | 28779 | $0.00 | 65,720.0000 | 189,471,298 | 77.91% | 0.02% |
| Dec. 23, 2025 | Baranick Brian | EVP, GM, Precision Oncology | F | Common Stock | 7539 | $101.82 | 36,941.0000 | 189,471,298 | 16.95% | 0.00% |
| Dec. 23, 2025 | Baranick Brian | EVP, GM, Precision Oncology | M | Common Stock | 14845 | $0.00 | 44,480.0000 | 189,471,298 | 50.09% | 0.01% |
| Dec. 23, 2025 | Baranick Brian | EVP, GM, Precision Oncology | F | Common Stock | 4799 | $101.82 | 29,635.0000 | 189,471,298 | 13.94% | 0.00% |
| Dec. 23, 2025 | Baranick Brian | EVP, GM, Precision Oncology | M | Common Stock | 9450 | $0.00 | 34,434.0000 | 189,471,298 | 37.82% | 0.00% |
| Dec. 23, 2025 | Baranick Brian | EVP, GM, Precision Oncology | F | Common Stock | 2009 | $101.82 | 24,984.0000 | 189,471,298 | 7.44% | 0.00% |
| Dec. 23, 2025 | Baranick Brian | EVP, GM, Precision Oncology | M | Common Stock | 3955 | $0.00 | 26,993.0000 | 189,471,298 | 17.17% | 0.00% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | M | Restricted Stock Units | 16051 | $0.00 | 0.0000 | 189,471,298 | 100.00% | 0.01% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | M | Restricted Stock Units | 28779 | $0.00 | 0.0000 | 189,471,298 | 100.00% | 0.02% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | M | Restricted Stock Units | 14845 | $0.00 | 0.0000 | 189,471,298 | 100.00% | 0.01% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | M | Restricted Stock Units | 9450 | $0.00 | 0.0000 | 189,471,298 | 100.00% | 0.00% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | M | Restricted Stock Units | 3955 | $0.00 | 0.0000 | 189,471,298 | 100.00% | 0.00% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | F | Common Stock | 4426 | $101.82 | 101,893.0000 | 189,471,298 | 4.16% | 0.00% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | A | Common Stock | 9416 | $0.00 | 106,319.0000 | 189,471,298 | 9.72% | 0.00% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | F | Common Stock | 9675 | $101.82 | 96,903.0000 | 189,471,298 | 9.08% | 0.01% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | A | Common Stock | 20584 | $0.00 | 106,578.0000 | 189,471,298 | 23.94% | 0.01% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | F | Common Stock | 19986 | $101.82 | 85,994.0000 | 189,471,298 | 18.86% | 0.01% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | A | Common Stock | 42523 | $0.00 | 105,980.0000 | 189,471,298 | 67.01% | 0.02% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | F | Common Stock | 7544 | $101.82 | 63,457.0000 | 189,471,298 | 10.63% | 0.00% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | M | Common Stock | 16051 | $0.00 | 71,001.0000 | 189,471,298 | 29.21% | 0.01% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | F | Common Stock | 13527 | $101.82 | 54,950.0000 | 189,471,298 | 19.75% | 0.01% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | M | Common Stock | 28779 | $0.00 | 68,477.0000 | 189,471,298 | 72.49% | 0.02% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | F | Common Stock | 6978 | $101.82 | 39,698.0000 | 189,471,298 | 14.95% | 0.00% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | M | Common Stock | 14845 | $0.00 | 46,676.0000 | 189,471,298 | 46.64% | 0.01% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | F | Common Stock | 4442 | $101.82 | 31,831.0000 | 189,471,298 | 12.25% | 0.00% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | M | Common Stock | 9450 | $0.00 | 36,273.0000 | 189,471,298 | 35.23% | 0.00% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | F | Common Stock | 1859 | $101.82 | 26,823.0000 | 189,471,298 | 6.48% | 0.00% |
| Dec. 23, 2025 | ORVILLE JACOB A | EVP, GM, Screening | M | Common Stock | 3955 | $0.00 | 28,682.0000 | 189,471,298 | 15.99% | 0.00% |
| Dec. 23, 2025 | Bloomer Aaron | EVP, Chief Financial Officer | M | Restricted Stock Units | 24384 | $0.00 | 4,395.0000 | 189,471,298 | 84.73% | 0.01% |
| Dec. 23, 2025 | Bloomer Aaron | EVP, Chief Financial Officer | M | Restricted Stock Units | 38715 | $0.00 | 0.0000 | 189,471,298 | 100.00% | 0.02% |
| Dec. 23, 2025 | Bloomer Aaron | EVP, Chief Financial Officer | F | Common Stock | 10803 | $101.82 | 48,980.0000 | 189,471,298 | 18.07% | 0.01% |
| Dec. 23, 2025 | Bloomer Aaron | EVP, Chief Financial Officer | M | Common Stock | 24384 | $0.00 | 59,783.0000 | 189,471,298 | 68.88% | 0.01% |
| Dec. 23, 2025 | Bloomer Aaron | EVP, Chief Financial Officer | F | Common Stock | 17151 | $101.82 | 35,399.0000 | 189,471,298 | 32.64% | 0.01% |
| Dec. 23, 2025 | Bloomer Aaron | EVP, Chief Financial Officer | M | Common Stock | 38715 | $0.00 | 52,550.0000 | 189,471,298 | 279.83% | 0.02% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | M | Restricted Stock Units | 7334 | $0.00 | 0.0000 | 189,471,298 | 100.00% | 0.00% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | M | Restricted Stock Units | 13893 | $0.00 | 0.0000 | 189,471,298 | 100.00% | 0.01% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | M | Restricted Stock Units | 7125 | $0.00 | 0.0000 | 189,471,298 | 100.00% | 0.00% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | M | Restricted Stock Units | 3780 | $0.00 | 0.0000 | 189,471,298 | 100.00% | 0.00% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | M | Restricted Stock Units | 1648 | $0.00 | 0.0000 | 189,471,298 | 100.00% | 0.00% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | F | Common Stock | 7118 | $101.82 | 69,371.0000 | 189,471,298 | 9.31% | 0.00% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | A | Common Stock | 15144 | $0.00 | 76,489.0000 | 189,471,298 | 24.69% | 0.01% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | F | Common Stock | 14235 | $101.82 | 61,345.0000 | 189,471,298 | 18.83% | 0.01% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | A | Common Stock | 30287 | $0.00 | 75,580.0000 | 189,471,298 | 66.87% | 0.02% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | F | Common Stock | 4644 | $101.82 | 45,293.0000 | 189,471,298 | 9.30% | 0.00% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | A | Common Stock | 9880 | $0.00 | 49,937.0000 | 189,471,298 | 24.66% | 0.01% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | F | Common Stock | 7995 | $101.82 | 40,057.0000 | 189,471,298 | 16.64% | 0.00% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | A | Common Stock | 17009 | $0.00 | 48,052.0000 | 189,471,298 | 54.79% | 0.01% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | F | Common Stock | 3447 | $101.82 | 31,043.0000 | 189,471,298 | 9.99% | 0.00% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | M | Common Stock | 7334 | $0.00 | 34,490.0000 | 189,471,298 | 27.01% | 0.00% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | F | Common Stock | 6530 | $101.82 | 27,156.0000 | 189,471,298 | 19.38% | 0.00% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | M | Common Stock | 13893 | $0.00 | 34,490.0000 | 189,471,298 | 67.45% | 0.01% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | F | Common Stock | 3349 | $101.82 | 19,793.0000 | 189,471,298 | 14.47% | 0.00% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | M | Common Stock | 7125 | $0.00 | 23,142.0000 | 189,471,298 | 44.48% | 0.00% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | F | Common Stock | 1777 | $101.82 | 16,017.0000 | 189,471,298 | 9.99% | 0.00% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | M | Common Stock | 3780 | $0.00 | 17,794.0000 | 189,471,298 | 26.97% | 0.00% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | F | Common Stock | 775 | $101.82 | 14,014.0000 | 189,471,298 | 5.24% | 0.00% |
| Dec. 23, 2025 | Herriott James | SVP, General Counsel & Sec | M | Common Stock | 1648 | $0.00 | 14,789.0000 | 189,471,298 | 12.54% | 0.00% |
| Dec. 23, 2025 | Conroy Kevin T | President and CEO | F | Common Stock | 155417 | $101.82 | 1,514,491.0000 | 189,471,298 | 9.31% | 0.08% |
| Dec. 23, 2025 | Conroy Kevin T | President and CEO | A | Common Stock | 330674 | $0.00 | 434,938.0000 | 189,471,298 | 317.15% | 0.17% |
| Dec. 23, 2025 | Conroy Kevin T | President and CEO | F | Common Stock | 65014 | $101.82 | 1,339,234.0000 | 189,471,298 | 4.63% | 0.03% |
| Dec. 23, 2025 | Conroy Kevin T | President and CEO | A | Common Stock | 138326 | $0.00 | 1,404,248.0000 | 189,471,298 | 10.93% | 0.07% |
| Dec. 23, 2025 | Conroy Kevin T | President and CEO | F | Common Stock | 115118 | $101.82 | 1,265,922.0000 | 189,471,298 | 8.34% | 0.06% |
| Dec. 23, 2025 | Conroy Kevin T | President and CEO | A | Common Stock | 244931 | $0.00 | 1,381,040.0000 | 189,471,298 | 21.56% | 0.13% |
| Dec. 23, 2025 | Condella Sarah | EVP, Human Resources | M | Restricted Stock Units | 23817 | $0.00 | 0.0000 | 189,471,298 | 100.00% | 0.01% |
| Dec. 23, 2025 | Condella Sarah | EVP, Human Resources | M | Restricted Stock Units | 11876 | $0.00 | 0.0000 | 189,471,298 | 100.00% | 0.01% |
| Dec. 23, 2025 | Condella Sarah | EVP, Human Resources | M | Restricted Stock Units | 7560 | $0.00 | 0.0000 | 189,471,298 | 100.00% | 0.00% |
| Dec. 23, 2025 | Condella Sarah | EVP, Human Resources | M | Restricted Stock Units | 3955 | $0.00 | 0.0000 | 189,471,298 | 100.00% | 0.00% |
| Dec. 23, 2025 | Condella Sarah | EVP, Human Resources | F | Common Stock | 3760 | $101.82 | 135,234.0000 | 189,471,298 | 2.71% | 0.00% |
| Dec. 23, 2025 | Condella Sarah | EVP, Human Resources | A | Common Stock | 8000 | $0.00 | 138,994.0000 | 189,471,298 | 6.11% | 0.00% |
| Dec. 23, 2025 | Condella Sarah | EVP, Human Resources | F | Common Stock | 15989 | $101.82 | 130,994.0000 | 189,471,298 | 10.88% | 0.01% |
| Dec. 23, 2025 | Condella Sarah | EVP, Human Resources | A | Common Stock | 34018 | $0.00 | 146,983.0000 | 189,471,298 | 30.11% | 0.02% |
| Dec. 23, 2025 | Condella Sarah | EVP, Human Resources | F | Common Stock | 11194 | $101.82 | 112,965.0000 | 189,471,298 | 9.02% | 0.01% |
| Dec. 23, 2025 | Condella Sarah | EVP, Human Resources | M | Common Stock | 23817 | $0.00 | 124,159.0000 | 189,471,298 | 23.74% | 0.01% |
| Dec. 23, 2025 | Condella Sarah | EVP, Human Resources | F | Common Stock | 5582 | $101.82 | 100,342.0000 | 189,471,298 | 5.27% | 0.00% |
| Dec. 23, 2025 | Condella Sarah | EVP, Human Resources | M | Common Stock | 11876 | $0.00 | 105,924.0000 | 189,471,298 | 12.63% | 0.01% |
| Dec. 23, 2025 | Condella Sarah | EVP, Human Resources | F | Common Stock | 3554 | $101.82 | 94,048.0000 | 189,471,298 | 3.64% | 0.00% |
| Dec. 23, 2025 | Condella Sarah | EVP, Human Resources | M | Common Stock | 7560 | $0.00 | 97,602.0000 | 189,471,298 | 8.40% | 0.00% |
| Dec. 23, 2025 | Condella Sarah | EVP, Human Resources | F | Common Stock | 1859 | $101.82 | 90,042.0000 | 189,471,298 | 2.02% | 0.00% |
| Nov. 19, 2025 | ORVILLE JACOB A | EVP, GM, Screening | S | Common Stock | 5000 | $75.00 | 24,727.0000 | 189,471,298 | 16.82% | 0.00% |
| Nov. 19, 2025 | Herriott James | SVP, General Counsel & Sec | S | Common Stock | 1000 | $70.00 | 13,141.0000 | 189,471,298 | 7.07% | 0.00% |
| Nov. 4, 2025 | Baranick Brian | EVP, GM, Precision Oncology | S | Common Stock | 2858 | $70.08 | 23,038.0000 | 189,471,298 | 11.04% | 0.00% |
| Nov. 4, 2025 | Herriott James | SVP, General Counsel & Sec | S | Common Stock | 1500 | $70.08 | 14,141.0000 | 189,471,298 | 9.59% | 0.00% |
| Oct. 24, 2025 | Zanotti Katherine S | Not found | S | Common Stock | 12000 | $65.00 | 60,759.0000 | 185,755,406 | 16.49% | 0.01% |
| Oct. 9, 2025 | Doyle James Edward | Not found | S | Common Stock | 2000 | $60.00 | 57,962.0000 | 185,755,406 | 3.34% | 0.00% |
| Oct. 9, 2025 | Herriott James | SVP, General Counsel & Sec | S | Common Stock | 1500 | $60.00 | 15,641.0000 | 185,755,406 | 8.75% | 0.00% |
| Aug. 13, 2025 | Doyle James Edward | Not found | S | Common Stock | 1485 | $42.02 | 59,962.0000 | 185,755,406 | 2.42% | 0.00% |
| Aug. 5, 2025 | ORVILLE JACOB A | EVP, GM, Screening | F | Common Stock | 2515 | $46.83 | 29,727.0000 | 185,755,406 | 7.80% | 0.00% |
| Aug. 5, 2025 | Baranick Brian | EVP, GM, Precision Oncology | F | Common Stock | 2717 | $46.83 | 25,896.0000 | 185,755,406 | 9.50% | 0.00% |
| Aug. 5, 2025 | Baranick Brian | EVP, GM, Precision Oncology | M | Restricted Stock Units | 5350 | $0.00 | 16,051.0000 | 185,755,406 | 25.00% | 0.00% |
| Aug. 5, 2025 | ORVILLE JACOB A | EVP, GM, Screening | M | Common Stock | 5350 | $0.00 | 32,242.0000 | 185,755,406 | 19.89% | 0.00% |
| Aug. 5, 2025 | Baranick Brian | EVP, GM, Precision Oncology | M | Common Stock | 5350 | $0.00 | 28,613.0000 | 185,755,406 | 23.00% | 0.00% |
| Aug. 5, 2025 | ORVILLE JACOB A | EVP, GM, Screening | M | Restricted Stock Units | 5350 | $0.00 | 16,051.0000 | 185,755,406 | 25.00% | 0.00% |
| June 12, 2025 | Clancy Paul J | Not found | A | Common Stock | 5398 | $0.00 | 26,038.0000 | 185,755,406 | 26.15% | 0.00% |
| June 12, 2025 | Barber Michael J | Not found | A | Common Stock | 7197 | $0.00 | 13,136.0000 | 185,755,406 | 121.18% | 0.00% |
| June 12, 2025 | Doyle James Edward | Not found | A | Common Stock | 5398 | $0.00 | 61,447.0000 | 185,755,406 | 9.63% | 0.00% |
| June 12, 2025 | COWARD D SCOTT | Not found | A | Common Stock | 5398 | $0.00 | 62,255.0000 | 185,755,406 | 9.49% | 0.00% |
| June 12, 2025 | LEVANGIE DANIEL J | Not found | A | Common Stock | 5398 | $0.00 | 34,312.0000 | 185,755,406 | 18.67% | 0.00% |
| June 13, 2025 | Zanotti Katherine S | Not found | S | Common Stock | 3207 | $53.20 | 72,759.0000 | 185,755,406 | 4.22% | 0.00% |
| June 12, 2025 | Zanotti Katherine S | Not found | A | Common Stock | 5398 | $0.00 | 75,966.0000 | 185,755,406 | 7.65% | 0.00% |
| June 12, 2025 | Petrovic Shacey | Not found | A | Common Stock | 5398 | $0.00 | 28,899.0000 | 185,755,406 | 22.97% | 0.00% |
| June 12, 2025 | Trigg Leslie | Not found | A | Common Stock | 7670 | $0.00 | 17,169.0000 | 185,755,406 | 80.75% | 0.00% |
| June 12, 2025 | Popovits Kimberly J | Not found | A | Common Stock | 9994 | $0.00 | 16,381.0000 | 185,755,406 | 156.47% | 0.01% |
| April 30, 2025 | Herriott James | SVP, General Counsel & Sec | A | Common Stock | 363 | $38.26 | 17,141.0000 | 185,755,406 | 2.16% | 0.00% |
| May 6, 2025 | Herriott James | SVP, General Counsel & Sec | A | Restricted Stock Units | 7334 | $0.00 | 7,334.0000 | 185,755,406 | 9999.99% | 0.00% |
| April 29, 2025 | Trigg Leslie | Not found | A | Common Stock | 8527 | $0.00 | 9,499.0000 | 185,755,406 | 877.26% | 0.00% |
| Nov. 27, 2019 | Conroy Kevin T | President and CEO | G | Common Stock | 43126 | $0.00 | 919,731.0000 | 0 | 4.92% | 0.00% |
| Oct. 26, 2020 | Conroy Kevin T | President and CEO | G | Common Stock | 163000 | $0.00 | 628,425.0000 | 0 | 20.60% | 0.00% |
| May 14, 2024 | Conroy Kevin T | President and CEO | G | Common Stock | 74599 | $0.00 | 1,054,875.0000 | 0 | 6.60% | 0.00% |
| May 6, 2019 | Conroy Kevin T | President and CEO | G | Common Stock | 28660 | $0.00 | 876,605.0000 | 0 | 3.17% | 0.00% |
| Nov. 27, 2019 | Conroy Kevin T | President and CEO | G | Common Stock | 43126 | $0.00 | 941,794.0000 | 0 | 4.38% | 0.00% |
| Nov. 27, 2019 | Conroy Kevin T | President and CEO | G | Common Stock | 22063 | $0.00 | 919,731.0000 | 0 | 2.34% | 0.00% |
| April 15, 2025 | Bloomer Aaron | EVP, Chief Financial Officer | M | Common Stock | 12904 | $0.00 | 19,552.0000 | 185,755,406 | 194.10% | 0.01% |
| April 15, 2025 | Bloomer Aaron | EVP, Chief Financial Officer | M | Common Stock | 11556 | $0.00 | 11,768.0000 | 185,755,406 | 5450.94% | 0.01% |
| April 15, 2025 | Bloomer Aaron | EVP, Chief Financial Officer | F | Common Stock | 5120 | $44.25 | 6,648.0000 | 185,755,406 | 43.51% | 0.00% |
| April 15, 2025 | Bloomer Aaron | EVP, Chief Financial Officer | F | Common Stock | 5717 | $44.25 | 13,835.0000 | 185,755,406 | 29.24% | 0.00% |
| April 15, 2025 | Bloomer Aaron | EVP, Chief Financial Officer | M | Restricted Stock Units | 12904 | $0.00 | 38,715.0000 | 185,755,406 | 25.00% | 0.01% |
| April 15, 2025 | Bloomer Aaron | EVP, Chief Financial Officer | M | Restricted Stock Units | 11566 | $0.00 | 0.0000 | 185,755,406 | 100.00% | 0.01% |
| March 7, 2025 | Conroy Kevin T | President and CEO | M | Common Stock | 66723 | $22.38 | 1,543,902.0000 | 185,755,406 | 4.52% | 0.04% |
| March 7, 2025 | Conroy Kevin T | President and CEO | F | Common Stock | 48929 | $47.06 | 1,494,973.0000 | 185,755,406 | 3.17% | 0.03% |
| March 7, 2025 | Conroy Kevin T | President and CEO | M | Stock Options (Right to Buy) | 66723 | $0.00 | 0.0000 | 185,755,406 | 100.00% | 0.04% |
| Feb. 28, 2025 | Condella Sarah | EVP, Human Resources | M | Common Stock | 3958 | $0.00 | 90,499.0000 | 185,755,406 | 4.57% | 0.00% |
| Feb. 28, 2025 | Herriott James | SVP, General Counsel & Sec | M | Common Stock | 1890 | $0.00 | 16,409.0000 | 185,755,406 | 13.02% | 0.00% |
| Feb. 28, 2025 | Herriott James | SVP, General Counsel & Sec | F | Common Stock | 889 | $47.82 | 15,520.0000 | 185,755,406 | 5.42% | 0.00% |
| Feb. 28, 2025 | Herriott James | SVP, General Counsel & Sec | M | Common Stock | 2375 | $0.00 | 17,895.0000 | 185,755,406 | 15.30% | 0.00% |
| Feb. 28, 2025 | Herriott James | SVP, General Counsel & Sec | F | Common Stock | 1117 | $47.82 | 16,778.0000 | 185,755,406 | 6.24% | 0.00% |
| Feb. 28, 2025 | Herriott James | SVP, General Counsel & Sec | M | Restricted Stock Units | 1890 | $0.00 | 3,780.0000 | 185,755,406 | 33.33% | 0.00% |
| Feb. 28, 2025 | Herriott James | SVP, General Counsel & Sec | M | Restricted Stock Units | 2375 | $0.00 | 7,125.0000 | 185,755,406 | 25.00% | 0.00% |
| Feb. 28, 2025 | Conroy Kevin T | President and CEO | M | Common Stock | 18143 | $0.00 | 1,473,959.0000 | 185,755,406 | 1.25% | 0.01% |
| Feb. 28, 2025 | Conroy Kevin T | President and CEO | F | Common Stock | 8528 | $47.82 | 1,465,431.0000 | 185,755,406 | 0.58% | 0.00% |
| Feb. 28, 2025 | Conroy Kevin T | President and CEO | M | Common Stock | 22167 | $0.00 | 1,487,598.0000 | 185,755,406 | 1.51% | 0.01% |
| Feb. 28, 2025 | Conroy Kevin T | President and CEO | F | Common Stock | 10419 | $47.82 | 1,477,179.0000 | 185,755,406 | 0.70% | 0.01% |
| Feb. 28, 2025 | Conroy Kevin T | President and CEO | M | Restricted Stock Units | 18143 | $0.00 | 36,286.0000 | 185,755,406 | 33.33% | 0.01% |
| Feb. 28, 2025 | Conroy Kevin T | President and CEO | M | Restricted Stock Units | 22167 | $0.00 | 66,504.0000 | 185,755,406 | 25.00% | 0.01% |
| Feb. 28, 2025 | Baranick Brian | EVP, GM, Precision Oncology | M | Common Stock | 4725 | $0.00 | 23,228.0000 | 185,755,406 | 25.54% | 0.00% |
| Feb. 28, 2025 | Baranick Brian | EVP, GM, Precision Oncology | F | Common Stock | 2400 | $47.82 | 20,828.0000 | 185,755,406 | 10.33% | 0.00% |
| Feb. 28, 2025 | Baranick Brian | EVP, GM, Precision Oncology | M | Common Stock | 4948 | $0.00 | 25,776.0000 | 185,755,406 | 23.76% | 0.00% |
| Feb. 28, 2025 | Baranick Brian | EVP, GM, Precision Oncology | F | Common Stock | 2513 | $47.82 | 23,263.0000 | 185,755,406 | 9.75% | 0.00% |
| Feb. 28, 2025 | Baranick Brian | EVP, GM, Precision Oncology | M | Restricted Stock Units | 4725 | $0.00 | 9,450.0000 | 185,755,406 | 33.33% | 0.00% |
| Feb. 28, 2025 | Baranick Brian | EVP, GM, Precision Oncology | M | Restricted Stock Units | 4948 | $0.00 | 14,845.0000 | 185,755,406 | 25.00% | 0.00% |
| Feb. 28, 2025 | ORVILLE JACOB A | EVP, GM, Screening | M | Common Stock | 4725 | $0.00 | 26,491.0000 | 185,755,406 | 21.71% | 0.00% |
| Feb. 28, 2025 | ORVILLE JACOB A | EVP, GM, Screening | F | Common Stock | 2221 | $47.82 | 24,270.0000 | 185,755,406 | 8.38% | 0.00% |
| Feb. 28, 2025 | ORVILLE JACOB A | EVP, GM, Screening | M | Common Stock | 4948 | $0.00 | 29,218.0000 | 185,755,406 | 20.39% | 0.00% |
| Feb. 28, 2025 | ORVILLE JACOB A | EVP, GM, Screening | F | Common Stock | 2326 | $47.82 | 26,892.0000 | 185,755,406 | 7.96% | 0.00% |
| Feb. 28, 2025 | ORVILLE JACOB A | EVP, GM, Screening | M | Restricted Stock Units | 4725 | $0.00 | 9,450.0000 | 185,755,406 | 33.33% | 0.00% |
| Feb. 28, 2025 | ORVILLE JACOB A | EVP, GM, Screening | M | Restricted Stock Units | 4948 | $0.00 | 14,845.0000 | 185,755,406 | 25.00% | 0.00% |
| Feb. 28, 2025 | Condella Sarah | EVP, Human Resources | M | Common Stock | 3780 | $0.00 | 88,318.0000 | 185,755,406 | 4.47% | 0.00% |
| Feb. 28, 2025 | Condella Sarah | EVP, Human Resources | F | Common Stock | 1777 | $47.82 | 86,541.0000 | 185,755,406 | 2.01% | 0.00% |
| Feb. 28, 2025 | Condella Sarah | EVP, Human Resources | F | Common Stock | 1861 | $47.82 | 88,638.0000 | 185,755,406 | 2.06% | 0.00% |
| March 3, 2025 | Condella Sarah | EVP, Human Resources | G | Common Stock | 1055 | $0.00 | 87,583.0000 | 185,755,406 | 1.19% | 0.00% |
| Feb. 28, 2025 | Condella Sarah | EVP, Human Resources | M | Restricted Stock Units | 3780 | $0.00 | 7,560.0000 | 185,755,406 | 33.33% | 0.00% |
| Feb. 28, 2025 | Condella Sarah | EVP, Human Resources | M | Restricted Stock Units | 3958 | $0.00 | 11,876.0000 | 185,755,406 | 25.00% | 0.00% |
| Feb. 25, 2025 | Baranick Brian | EVP, GM, Precision Oncology | F | Common Stock | 2008 | $51.28 | 18,503.0000 | 185,755,406 | 9.79% | 0.00% |
| Feb. 25, 2025 | Conroy Kevin T | President and CEO | M | Restricted Stock Units | 13180 | $0.00 | 13,181.0000 | 185,755,406 | 50.00% | 0.01% |
| Feb. 24, 2025 | Conroy Kevin T | President and CEO | A | Restricted Stock Units | 111146 | $0.00 | 111,146.0000 | 185,755,406 | 9999.99% | 0.06% |
| Feb. 25, 2025 | Conroy Kevin T | President and CEO | F | Common Stock | 6195 | $51.28 | 1,455,785.0000 | 185,755,406 | 0.42% | 0.00% |
| Feb. 25, 2025 | Conroy Kevin T | President and CEO | M | Common Stock | 13180 | $0.00 | 1,461,980.0000 | 185,755,406 | 0.91% | 0.01% |
| Feb. 24, 2025 | Bloomer Aaron | EVP, Chief Financial Officer | A | Restricted Stock Units | 28779 | $0.00 | 28,779.0000 | 185,755,406 | 9999.99% | 0.02% |
| Feb. 25, 2025 | ORVILLE JACOB A | EVP, GM, Screening | M | Restricted Stock Units | 3954 | $0.00 | 3,955.0000 | 185,755,406 | 49.99% | 0.00% |
| Feb. 24, 2025 | ORVILLE JACOB A | EVP, GM, Screening | A | Restricted Stock Units | 28779 | $0.00 | 28,779.0000 | 185,755,406 | 9999.99% | 0.02% |
| Feb. 25, 2025 | ORVILLE JACOB A | EVP, GM, Screening | F | Common Stock | 1859 | $51.28 | 21,767.0000 | 185,755,406 | 7.87% | 0.00% |
| Feb. 25, 2025 | ORVILLE JACOB A | EVP, GM, Screening | M | Common Stock | 3954 | $0.00 | 23,626.0000 | 185,755,406 | 20.10% | 0.00% |
| Feb. 25, 2025 | Condella Sarah | EVP, Human Resources | M | Common Stock | 3954 | $0.00 | 86,397.0000 | 185,755,406 | 4.80% | 0.00% |
| Feb. 25, 2025 | Condella Sarah | EVP, Human Resources | F | Common Stock | 1859 | $51.28 | 84,538.0000 | 185,755,406 | 2.15% | 0.00% |
| Feb. 24, 2025 | Condella Sarah | EVP, Human Resources | A | Restricted Stock Units | 23817 | $0.00 | 23,817.0000 | 185,755,406 | 9999.99% | 0.01% |
| Feb. 25, 2025 | Condella Sarah | EVP, Human Resources | M | Restricted Stock Units | 3954 | $0.00 | 3,955.0000 | 185,755,406 | 49.99% | 0.00% |
| Feb. 25, 2025 | Baranick Brian | EVP, GM, Precision Oncology | M | Common Stock | 3954 | $0.00 | 20,511.0000 | 185,755,406 | 23.88% | 0.00% |
| Feb. 25, 2025 | Herriott James | SVP, General Counsel & Sec | M | Restricted Stock Units | 1647 | $0.00 | 1,648.0000 | 185,755,406 | 49.98% | 0.00% |
| Feb. 24, 2025 | Herriott James | SVP, General Counsel & Sec | A | Restricted Stock Units | 13893 | $0.00 | 13,893.0000 | 185,755,406 | 9999.99% | 0.01% |
| Feb. 25, 2025 | Herriott James | SVP, General Counsel & Sec | F | Common Stock | 775 | $51.28 | 14,519.0000 | 185,755,406 | 5.07% | 0.00% |
| Feb. 25, 2025 | Herriott James | SVP, General Counsel & Sec | M | Common Stock | 1647 | $0.00 | 15,294.0000 | 185,755,406 | 12.07% | 0.00% |
| Feb. 25, 2025 | Baranick Brian | EVP, GM, Precision Oncology | M | Restricted Stock Units | 3954 | $0.00 | 3,955.0000 | 185,755,406 | 49.99% | 0.00% |
| Feb. 24, 2025 | Baranick Brian | EVP, GM, Precision Oncology | A | Restricted Stock Units | 28779 | $0.00 | 28,779.0000 | 185,755,406 | 9999.99% | 0.02% |
| Feb. 19, 2025 | Condella Sarah | EVP, Human Resources | M | Restricted Stock Units | 2248 | $0.00 | 0.0000 | 185,755,406 | 100.00% | 0.00% |
| Feb. 19, 2025 | Conroy Kevin T | President and CEO | M | Common Stock | 10374 | $0.00 | 1,425,167.0000 | 185,755,406 | 0.73% | 0.01% |
| Feb. 19, 2025 | Conroy Kevin T | President and CEO | F | Common Stock | 3271 | $49.63 | 1,421,896.0000 | 185,755,406 | 0.23% | 0.00% |
| Feb. 20, 2025 | Conroy Kevin T | President and CEO | A | Common Stock | 48044 | $0.00 | 1,469,940.0000 | 185,755,406 | 3.38% | 0.03% |
| Feb. 20, 2025 | Conroy Kevin T | President and CEO | F | Common Stock | 21140 | $50.48 | 1,448,800.0000 | 185,755,406 | 1.44% | 0.01% |
| Feb. 19, 2025 | Conroy Kevin T | President and CEO | M | Restricted Stock Units | 10374 | $0.00 | 0.0000 | 185,755,406 | 100.00% | 0.01% |
| Feb. 19, 2025 | COWARD D SCOTT | Not found | M | Common Stock | 2248 | $0.00 | 57,524.0000 | 185,755,406 | 4.07% | 0.00% |
| Feb. 19, 2025 | COWARD D SCOTT | Not found | F | Common Stock | 667 | $49.63 | 56,857.0000 | 185,755,406 | 1.16% | 0.00% |
| Feb. 19, 2025 | COWARD D SCOTT | Not found | M | Restricted Stock Units | 2248 | $0.00 | 0.0000 | 185,755,406 | 100.00% | 0.00% |
| Feb. 19, 2025 | ORVILLE JACOB A | EVP, GM, Screening | M | Common Stock | 2248 | $0.00 | 18,178.0000 | 185,755,406 | 14.11% | 0.00% |
| Feb. 19, 2025 | ORVILLE JACOB A | EVP, GM, Screening | F | Common Stock | 1086 | $49.63 | 17,092.0000 | 185,755,406 | 5.97% | 0.00% |
| Feb. 20, 2025 | ORVILLE JACOB A | EVP, GM, Screening | A | Common Stock | 4805 | $0.00 | 21,897.0000 | 185,755,406 | 28.11% | 0.00% |
| Feb. 20, 2025 | ORVILLE JACOB A | EVP, GM, Screening | F | Common Stock | 2225 | $50.48 | 19,672.0000 | 185,755,406 | 10.16% | 0.00% |
| Feb. 19, 2025 | ORVILLE JACOB A | EVP, GM, Screening | M | Restricted Stock Units | 2248 | $0.00 | 0.0000 | 185,755,406 | 100.00% | 0.00% |
| Feb. 19, 2025 | Baranick Brian | EVP, GM, Precision Oncology | M | Common Stock | 1729 | $0.00 | 15,157.0000 | 185,755,406 | 12.88% | 0.00% |
| Feb. 19, 2025 | Baranick Brian | EVP, GM, Precision Oncology | F | Common Stock | 968 | $49.63 | 14,189.0000 | 185,755,406 | 6.39% | 0.00% |
| Feb. 20, 2025 | Baranick Brian | EVP, GM, Precision Oncology | A | Common Stock | 4805 | $0.00 | 18,994.0000 | 185,755,406 | 33.86% | 0.00% |
| Feb. 20, 2025 | Baranick Brian | EVP, GM, Precision Oncology | F | Common Stock | 2437 | $50.48 | 16,557.0000 | 185,755,406 | 12.83% | 0.00% |
| Feb. 19, 2025 | Baranick Brian | EVP, GM, Precision Oncology | M | Restricted Stock Units | 1729 | $0.00 | 0.0000 | 185,755,406 | 100.00% | 0.00% |
| Feb. 19, 2025 | Condella Sarah | EVP, Human Resources | M | Common Stock | 2248 | $0.00 | 80,959.0000 | 185,755,406 | 2.86% | 0.00% |
| Feb. 19, 2025 | Condella Sarah | EVP, Human Resources | F | Common Stock | 1107 | $49.63 | 79,852.0000 | 185,755,406 | 1.37% | 0.00% |
| Feb. 20, 2025 | Condella Sarah | EVP, Human Resources | A | Common Stock | 4805 | $0.00 | 84,657.0000 | 185,755,406 | 6.02% | 0.00% |
| Feb. 20, 2025 | Condella Sarah | EVP, Human Resources | F | Common Stock | 2214 | $50.48 | 82,443.0000 | 185,755,406 | 2.62% | 0.00% |
| Feb. 19, 2025 | Herriott James | SVP, General Counsel & Sec | M | Common Stock | 865 | $0.00 | 12,287.0000 | 185,755,406 | 7.57% | 0.00% |
| Feb. 19, 2025 | Herriott James | SVP, General Counsel & Sec | F | Common Stock | 433 | $49.63 | 11,854.0000 | 185,755,406 | 3.52% | 0.00% |
| Feb. 20, 2025 | Herriott James | SVP, General Counsel & Sec | A | Common Stock | 3324 | $0.00 | 15,178.0000 | 185,755,406 | 28.04% | 0.00% |
| Feb. 20, 2025 | Herriott James | SVP, General Counsel & Sec | F | Common Stock | 1531 | $50.48 | 13,647.0000 | 185,755,406 | 10.09% | 0.00% |
| Feb. 19, 2025 | Herriott James | SVP, General Counsel & Sec | M | Restricted Stock Units | 865 | $0.00 | 0.0000 | 185,755,406 | 100.00% | 0.00% |
| Jan. 2, 2025 | Popovits Kimberly J | Not found | A | Common Stock | 6387 | $0.00 | 6,387.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Sebelius Kathleen | Not found | A | Common Stock | 7672 | $0.00 | 32,671.0000 | 0 | 30.69% | 0.00% |
| June 13, 2024 | COWARD D SCOTT | Not found | A | Common Stock | 5939 | $0.00 | 50,583.0000 | 0 | 13.30% | 0.00% |
| June 13, 2024 | Clancy Paul J | Not found | A | Common Stock | 5939 | $0.00 | 20,640.0000 | 0 | 40.40% | 0.00% |
| June 13, 2024 | Doyle James Edward | Not found | A | Common Stock | 5939 | $0.00 | 56,049.0000 | 0 | 11.85% | 0.00% |
| June 13, 2024 | Barber Michael J | Not found | A | Common Stock | 5939 | $0.00 | 5,939.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | LEVANGIE DANIEL J | Not found | A | Common Stock | 5939 | $0.00 | 28,914.0000 | 0 | 25.85% | 0.00% |
| June 13, 2024 | Zanotti Katherine S | Not found | A | Common Stock | 5939 | $0.00 | 70,568.0000 | 0 | 9.19% | 0.00% |
| June 13, 2024 | Petrovic Shacey | Not found | A | Common Stock | 5939 | $0.00 | 16,406.0000 | 0 | 56.74% | 0.00% |
| Nov. 13, 2024 | Conroy Kevin T | President and CEO | P | Common Stock | 19500 | $51.35 | 1,414,311.0000 | 0 | 1.40% | 0.00% |
| Oct. 8, 2024 | Baranick Brian | EVP, GM, Precision Oncology | S | Common Stock | 929 | $70.00 | 13,212.0000 | 0 | 6.57% | 0.00% |
| Sept. 18, 2024 | Baranick Brian | EVP, GM, Precision Oncology | S | Common Stock | 929 | $70.00 | 14,141.0000 | 0 | 6.16% | 0.00% |
| Aug. 5, 2024 | ORVILLE JACOB A | EVP, GM, Screening | A | Restricted Stock Units | 21401 | $0.00 | 21,401.0000 | 0 | 9999.99% | 0.00% |
| Aug. 5, 2024 | Baranick Brian | EVP, GM, Precision Oncology | M | Common Stock | 2712 | $0.00 | 16,445.0000 | 0 | 19.75% | 0.00% |
| Aug. 5, 2024 | Baranick Brian | EVP, GM, Precision Oncology | F | Common Stock | 1375 | $55.77 | 15,070.0000 | 0 | 8.36% | 0.00% |
| Aug. 5, 2024 | Baranick Brian | EVP, GM, Precision Oncology | M | Restricted Stock Units | 2712 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 5, 2024 | Baranick Brian | EVP, GM, Precision Oncology | A | Restricted Stock Units | 21401 | $0.00 | 21,401.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Sebelius Kathleen | Not found | A | Common Stock | 6889 | $0.00 | 31,888.0000 | 0 | 27.56% | 0.00% |
| June 13, 2024 | Doyle James Edward | Not found | A | Common Stock | 5444 | $0.00 | 55,554.0000 | 0 | 10.86% | 0.00% |
| June 13, 2024 | Petrovic Shacey | Not found | A | Common Stock | 5444 | $0.00 | 23,006.0000 | 0 | 31.00% | 0.00% |
| June 13, 2024 | Barber Michael J | Not found | A | Common Stock | 5444 | $0.00 | 5,444.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Barber Michael J | Not found | A | Deferred Stock Units | 7422 | $0.00 | 7,422.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | COWARD D SCOTT | Not found | A | Common Stock | 5444 | $0.00 | 54,781.0000 | 0 | 11.03% | 0.00% |
| June 13, 2024 | LEVANGIE DANIEL J | Not found | A | Common Stock | 5444 | $0.00 | 28,419.0000 | 0 | 23.70% | 0.00% |
| June 13, 2024 | Zanotti Katherine S | Not found | A | Common Stock | 5444 | $0.00 | 70,073.0000 | 0 | 8.42% | 0.00% |
| June 13, 2024 | Clancy Paul J | Not found | A | Common Stock | 5444 | $0.00 | 20,145.0000 | 0 | 37.03% | 0.00% |
| April 30, 2024 | Conroy Kevin T | President and CEO | A | Common Stock | 2489 | $0.00 | 1,395,217.0000 | 0 | 0.18% | 0.00% |
| May 1, 2024 | Conroy Kevin T | President and CEO | S | Common Stock | 1155 | $60.15 | 1,394,770.0000 | 0 | 0.08% | 0.00% |
| April 30, 2024 | ORVILLE JACOB A | General Manager, Screening | A | Common Stock | 218 | $0.00 | 15,659.0000 | 0 | 1.41% | 0.00% |
| May 1, 2024 | ORVILLE JACOB A | General Manager, Screening | S | Common Stock | 102 | $60.15 | 15,557.0000 | 0 | 0.65% | 0.00% |
| April 30, 2024 | Conroy Kevin T | President and CEO | A | Common Stock | 708 | $30.02 | 1,395,925.0000 | 0 | 0.05% | 0.00% |
| April 30, 2024 | Condella Sarah | EVP, Human Resources | A | Common Stock | 708 | $30.02 | 78,439.0000 | 0 | 0.91% | 0.00% |
| April 30, 2024 | Condella Sarah | EVP, Human Resources | A | Common Stock | 218 | $0.00 | 77,731.0000 | 0 | 0.28% | 0.00% |
| May 1, 2024 | Condella Sarah | EVP, Human Resources | S | Common Stock | 102 | $60.15 | 78,337.0000 | 0 | 0.13% | 0.00% |
| May 1, 2024 | Baranick Brian | EVP, GM., Precision Oncology | S | Common Stock | 110 | $60.15 | 13,733.0000 | 0 | 0.79% | 0.00% |
| April 30, 2024 | Baranick Brian | EVP, GM., Precision Oncology | A | Common Stock | 218 | $0.00 | 13,843.0000 | 0 | 1.60% | 0.00% |
| May 1, 2024 | Elliott Jeffrey Thomas | Chief Financial Officer | S | Common Stock | 136 | $60.15 | 13,380.0000 | 0 | 1.01% | 0.00% |
| April 30, 2024 | Elliott Jeffrey Thomas | Chief Financial Officer | A | Common Stock | 707 | $30.02 | 13,516.0000 | 0 | 5.52% | 0.00% |
| April 30, 2024 | Elliott Jeffrey Thomas | Chief Financial Officer | A | Common Stock | 291 | $0.00 | 12,809.0000 | 0 | 2.32% | 0.00% |
| May 1, 2024 | Herriott James | SVP, General Counsel & Sec | S | Common Stock | 30 | $60.15 | 11,049.0000 | 0 | 0.27% | 0.00% |
| April 30, 2024 | Cunningham Everett | Chief Commercial Officer | A | Common Stock | 708 | $30.02 | 47,749.0000 | 0 | 1.51% | 0.00% |
| May 1, 2024 | Cunningham Everett | Chief Commercial Officer | S | Common Stock | 136 | $60.15 | 47,613.0000 | 0 | 0.28% | 0.00% |
| April 30, 2024 | Herriott James | SVP, General Counsel & Sec | A | Common Stock | 63 | $0.00 | 10,371.0000 | 0 | 0.61% | 0.00% |
| April 30, 2024 | Herriott James | SVP, General Counsel & Sec | A | Common Stock | 708 | $30.02 | 11,079.0000 | 0 | 6.83% | 0.00% |
| April 30, 2024 | COWARD D SCOTT | Not found | A | Common Stock | 218 | $0.00 | 49,404.0000 | 0 | 0.44% | 0.00% |
| May 1, 2024 | COWARD D SCOTT | Not found | S | Common Stock | 67 | $60.15 | 49,337.0000 | 0 | 0.14% | 0.00% |
| April 30, 2024 | Cunningham Everett | Chief Commercial Officer | A | Common Stock | 291 | $0.00 | 47,041.0000 | 0 | 0.62% | 0.00% |
| April 1, 2024 | Condella Sarah | EVP, Human Resources | S | Common Stock | 2000 | $70.00 | 77,513.0000 | 0 | 2.52% | 0.00% |
| April 2, 2024 | Baranick Brian | EVP, GM., Precision Oncology | S | Common Stock | 924 | $79.43 | 13,625.0000 | 0 | 6.35% | 0.00% |
| March 28, 2024 | Condella Sarah | EVP, Human Resources | S | Common Stock | 2000 | $70.00 | 79,513.0000 | 0 | 2.45% | 0.00% |
| Feb. 29, 2024 | Elliott Jeffrey Thomas | Chief Financial Officer | M | Common Stock | 5291 | $0.00 | 14,930.0000 | 0 | 54.89% | 0.00% |
| Feb. 29, 2024 | Baranick Brian | Gen. Mgr., Precision Oncology | M | Restricted Stock Units | 4724 | $0.00 | 14,175.0000 | 0 | 25.00% | 0.00% |
| March 1, 2024 | Baranick Brian | Gen. Mgr., Precision Oncology | S | Common Stock | 2323 | $59.32 | 14,549.0000 | 0 | 13.77% | 0.00% |
| Feb. 29, 2024 | Baranick Brian | Gen. Mgr., Precision Oncology | M | Common Stock | 4724 | $0.00 | 16,872.0000 | 0 | 38.89% | 0.00% |
| Feb. 29, 2024 | Condella Sarah | EVP, Human Resources | M | Restricted Stock Units | 3779 | $0.00 | 11,340.0000 | 0 | 25.00% | 0.00% |
| March 1, 2024 | Condella Sarah | EVP, Human Resources | S | Common Stock | 1724 | $59.32 | 81,513.0000 | 0 | 2.07% | 0.00% |
| Feb. 29, 2024 | Condella Sarah | EVP, Human Resources | M | Common Stock | 3779 | $0.00 | 83,237.0000 | 0 | 4.76% | 0.00% |
| Feb. 29, 2024 | Conroy Kevin T | President and CEO | M | Restricted Stock Units | 18143 | $0.00 | 54,429.0000 | 0 | 25.00% | 0.00% |
| March 1, 2024 | Conroy Kevin T | President and CEO | S | Common Stock | 8271 | $59.32 | 1,392,609.0000 | 0 | 0.59% | 0.00% |
| Feb. 29, 2024 | Conroy Kevin T | President and CEO | M | Common Stock | 18143 | $0.00 | 1,400,880.0000 | 0 | 1.31% | 0.00% |
| Feb. 29, 2024 | Cunningham Everett | Chief Commercial Officer | M | Restricted Stock Units | 5291 | $0.00 | 15,876.0000 | 0 | 25.00% | 0.00% |
| March 1, 2024 | Cunningham Everett | Chief Commercial Officer | S | Common Stock | 2412 | $59.32 | 46,750.0000 | 0 | 4.91% | 0.00% |
| Feb. 29, 2024 | Cunningham Everett | Chief Commercial Officer | M | Common Stock | 5291 | $0.00 | 49,162.0000 | 0 | 12.06% | 0.00% |
| March 1, 2024 | Doyle James Edward | Director | S | Common Stock | 2000 | $57.50 | 50,110.0000 | 0 | 3.84% | 0.00% |
| Feb. 29, 2024 | Elliott Jeffrey Thomas | Chief Financial Officer | M | Restricted Stock Units | 5291 | $0.00 | 15,876.0000 | 0 | 25.00% | 0.00% |
| March 1, 2024 | Elliott Jeffrey Thomas | Chief Financial Officer | S | Common Stock | 2412 | $59.32 | 12,518.0000 | 0 | 16.16% | 0.00% |
| Feb. 29, 2024 | Herriott James | General Counsel | M | Restricted Stock Units | 1890 | $0.00 | 5,670.0000 | 0 | 25.00% | 0.00% |
| March 1, 2024 | Herriott James | General Counsel | S | Common Stock | 862 | $59.32 | 10,308.0000 | 0 | 7.72% | 0.00% |
| Feb. 29, 2024 | Herriott James | General Counsel | M | Common Stock | 1890 | $0.00 | 11,170.0000 | 0 | 20.37% | 0.00% |
| March 1, 2024 | LEVANGIE DANIEL J | Director | S | Common Stock | 5000 | $57.50 | 22,975.0000 | 0 | 17.87% | 0.00% |
| Feb. 29, 2024 | ORVILLE JACOB A | General Manager, Screening | M | Restricted Stock Units | 4724 | $0.00 | 14,175.0000 | 0 | 25.00% | 0.00% |
| March 1, 2024 | ORVILLE JACOB A | General Manager, Screening | S | Common Stock | 2154 | $59.32 | 15,441.0000 | 0 | 12.24% | 0.00% |
| Feb. 29, 2024 | ORVILLE JACOB A | General Manager, Screening | M | Common Stock | 4724 | $0.00 | 17,595.0000 | 0 | 36.70% | 0.00% |
| Feb. 26, 2024 | Baranick Brian | Gen. Mgr., Precision Oncology | A | Restricted Stock Units | 19793 | $0.00 | 19,793.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2024 | ORVILLE JACOB A | General Manager, Screening | M | Common Stock | 3954 | $0.00 | 14,750.0000 | 0 | 36.62% | 0.00% |
| Feb. 27, 2024 | ORVILLE JACOB A | General Manager, Screening | S | Common Stock | 1879 | $56.89 | 12,871.0000 | 0 | 12.74% | 0.00% |
| Feb. 26, 2024 | ORVILLE JACOB A | General Manager, Screening | M | Restricted Stock Units | 3954 | $0.00 | 7,909.0000 | 0 | 33.33% | 0.00% |
| Feb. 26, 2024 | ORVILLE JACOB A | General Manager, Screening | A | Restricted Stock Units | 19793 | $0.00 | 19,793.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2024 | Herriott James | General Counsel | M | Common Stock | 1648 | $0.00 | 10,064.0000 | 0 | 19.58% | 0.00% |
| Feb. 27, 2024 | Herriott James | General Counsel | S | Common Stock | 784 | $56.89 | 9,280.0000 | 0 | 7.79% | 0.00% |
| Feb. 26, 2024 | Herriott James | General Counsel | M | Restricted Stock Units | 1648 | $0.00 | 3,295.0000 | 0 | 33.34% | 0.00% |
| Feb. 26, 2024 | Herriott James | General Counsel | A | Restricted Stock Units | 9500 | $0.00 | 9,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2024 | Cunningham Everett | Chief Commercial Officer | M | Common Stock | 7678 | $0.00 | 47,519.0000 | 0 | 19.27% | 0.00% |
| Feb. 27, 2024 | Cunningham Everett | Chief Commercial Officer | S | Common Stock | 3648 | $56.89 | 43,871.0000 | 0 | 7.68% | 0.00% |
| Feb. 26, 2024 | Cunningham Everett | Chief Commercial Officer | M | Restricted Stock Units | 7678 | $0.00 | 15,356.0000 | 0 | 33.33% | 0.00% |
| Feb. 26, 2024 | Cunningham Everett | Chief Commercial Officer | A | Restricted Stock Units | 31668 | $0.00 | 31,668.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2024 | Elliott Jeffrey Thomas | Chief Financial Officer | M | Common Stock | 5701 | $0.00 | 12,349.0000 | 0 | 85.76% | 0.00% |
| Feb. 27, 2024 | Elliott Jeffrey Thomas | Chief Financial Officer | S | Common Stock | 2710 | $56.89 | 9,639.0000 | 0 | 21.95% | 0.00% |
| Feb. 26, 2024 | Elliott Jeffrey Thomas | Chief Financial Officer | M | Restricted Stock Units | 5701 | $0.00 | 11,401.0000 | 0 | 33.34% | 0.00% |
| Feb. 26, 2024 | Elliott Jeffrey Thomas | Chief Financial Officer | A | Restricted Stock Units | 4750 | $0.00 | 4,750.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2024 | Conroy Kevin T | President and CEO | M | Common Stock | 13181 | $0.00 | 1,389,000.0000 | 0 | 0.96% | 0.00% |
| Feb. 27, 2024 | Conroy Kevin T | President and CEO | S | Common Stock | 6263 | $56.89 | 1,382,737.0000 | 0 | 0.45% | 0.00% |
| Feb. 26, 2024 | Conroy Kevin T | President and CEO | M | Restricted Stock Units | 13181 | $0.00 | 26,361.0000 | 0 | 33.33% | 0.00% |
| Feb. 26, 2024 | Conroy Kevin T | President and CEO | A | Restricted Stock Units | 88671 | $0.00 | 88,671.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2024 | Condella Sarah | EVP, Human Resources | M | Common Stock | 3954 | $0.00 | 81,338.0000 | 0 | 5.11% | 0.00% |
| Feb. 27, 2024 | Condella Sarah | EVP, Human Resources | S | Common Stock | 1880 | $56.89 | 79,458.0000 | 0 | 2.31% | 0.00% |
| Feb. 26, 2024 | Condella Sarah | EVP, Human Resources | M | Restricted Stock Units | 3954 | $0.00 | 7,909.0000 | 0 | 33.33% | 0.00% |
| Feb. 26, 2024 | Condella Sarah | EVP, Human Resources | A | Restricted Stock Units | 15834 | $0.00 | 15,834.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2024 | Baranick Brian | Gen. Mgr., Precision Oncology | M | Common Stock | 3954 | $0.00 | 14,175.0000 | 0 | 38.69% | 0.00% |
| Feb. 27, 2024 | Baranick Brian | Gen. Mgr., Precision Oncology | S | Common Stock | 2027 | $56.89 | 12,148.0000 | 0 | 14.30% | 0.00% |
| Feb. 26, 2024 | Baranick Brian | Gen. Mgr., Precision Oncology | M | Restricted Stock Units | 3954 | $0.00 | 7,909.0000 | 0 | 33.33% | 0.00% |
| Feb. 23, 2024 | Conroy Kevin T | President and CEO | M | Stock Option (right to buy) | 102837 | $0.00 | 0.0000 | 0 | 0.00% | 0.00% |
| Feb. 23, 2024 | Conroy Kevin T | President and CEO | M | Common Stock | 102837 | $13.96 | 1,437,379.0000 | 0 | 7.71% | 0.00% |
| Feb. 23, 2024 | Conroy Kevin T | President and CEO | F | Common Stock | 61560 | $57.53 | 1,375,819.0000 | 0 | 4.28% | 0.00% |
| Feb. 23, 2024 | Condella Sarah | EVP, Human Resources | S | Common Stock | 1021 | $59.72 | 77,384.0000 | 0 | 1.30% | 0.00% |
| Feb. 22, 2024 | ORVILLE JACOB A | General Manager, Screening | S | Common Stock | 1013 | $59.78 | 10,796.0000 | 0 | 8.58% | 0.00% |
| Feb. 21, 2024 | ORVILLE JACOB A | General Manager, Screening | A | Common Stock | 2034 | $0.00 | 11,809.0000 | 0 | 20.81% | 0.00% |
| Feb. 21, 2024 | Herriott James | General Counsel | A | Common Stock | 581 | $0.00 | 8,707.0000 | 0 | 7.15% | 0.00% |
| Feb. 22, 2024 | Herriott James | General Counsel | S | Common Stock | 291 | $59.78 | 8,416.0000 | 0 | 3.34% | 0.00% |
| Feb. 21, 2024 | Elliott Jeffrey Thomas | Chief Financial Officer | A | Common Stock | 2711 | $0.00 | 7,999.0000 | 0 | 51.27% | 0.00% |
| Feb. 22, 2024 | Elliott Jeffrey Thomas | Chief Financial Officer | S | Common Stock | 1351 | $59.78 | 6,648.0000 | 0 | 16.89% | 0.00% |
| Feb. 21, 2024 | Cunningham Everett | Chief Commercial Officer | A | Common Stock | 2711 | $0.00 | 41,191.0000 | 0 | 7.05% | 0.00% |
| Feb. 22, 2024 | Cunningham Everett | Chief Commercial Officer | S | Common Stock | 1350 | $59.78 | 39,841.0000 | 0 | 3.28% | 0.00% |
| Feb. 21, 2024 | COWARD D SCOTT | Director | A | Common Stock | 2034 | $0.00 | 49,850.0000 | 0 | 4.25% | 0.00% |
| Feb. 22, 2024 | COWARD D SCOTT | Director | S | Common Stock | 663 | $59.78 | 49,187.0000 | 0 | 1.33% | 0.00% |
| Feb. 21, 2024 | Conroy Kevin T | President and CEO | A | Common Stock | 23238 | $0.00 | 1,346,107.0000 | 0 | 1.76% | 0.00% |
| Feb. 22, 2024 | Conroy Kevin T | President and CEO | S | Common Stock | 11565 | $59.78 | 1,334,542.0000 | 0 | 0.86% | 0.00% |
| Feb. 21, 2024 | Condella Sarah | EVP, Human Resources | A | Common Stock | 2034 | $0.00 | 79,418.0000 | 0 | 2.63% | 0.00% |
| Feb. 22, 2024 | Condella Sarah | EVP, Human Resources | S | Common Stock | 1013 | $59.78 | 78,405.0000 | 0 | 1.28% | 0.00% |
| Feb. 21, 2024 | Baranick Brian | Gen. Mgr., Precision Oncology | A | Common Stock | 2034 | $0.00 | 11,314.0000 | 0 | 21.92% | 0.00% |
| Feb. 22, 2024 | Baranick Brian | Gen. Mgr., Precision Oncology | S | Common Stock | 1093 | $59.78 | 10,221.0000 | 0 | 9.66% | 0.00% |
| Feb. 20, 2024 | COWARD D SCOTT | Director | M | Common Stock | 2248 | $0.00 | 48,522.0000 | 0 | 4.86% | 0.00% |
| Feb. 20, 2024 | ORVILLE JACOB A | General Manager, Screening | M | Common Stock | 2248 | $0.00 | 10,853.0000 | 0 | 26.12% | 0.00% |
| Feb. 21, 2024 | ORVILLE JACOB A | General Manager, Screening | S | Common Stock | 1078 | $61.50 | 9,775.0000 | 0 | 9.93% | 0.00% |
| Feb. 20, 2024 | ORVILLE JACOB A | General Manager, Screening | M | Restricted Stock Units | 2248 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 20, 2024 | Herriott James | General Counsel | M | Common Stock | 864 | $0.00 | 8,541.0000 | 0 | 11.25% | 0.00% |
| Feb. 21, 2024 | Herriott James | General Counsel | S | Common Stock | 415 | $61.50 | 8,126.0000 | 0 | 4.86% | 0.00% |
| Feb. 20, 2024 | Herriott James | General Counsel | M | Restricted Stock Units | 864 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 20, 2024 | Elliott Jeffrey Thomas | Chief Financial Officer | M | Common Stock | 3112 | $0.00 | 6,781.0000 | 0 | 84.82% | 0.00% |
| Feb. 21, 2024 | Elliott Jeffrey Thomas | Chief Financial Officer | S | Common Stock | 1493 | $61.50 | 5,288.0000 | 0 | 22.02% | 0.00% |
| Feb. 20, 2024 | Elliott Jeffrey Thomas | Chief Financial Officer | M | Restricted Stock Units | 3112 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 21, 2024 | COWARD D SCOTT | Director | S | Common Stock | 706 | $61.50 | 47,816.0000 | 0 | 1.46% | 0.00% |
| Feb. 20, 2024 | COWARD D SCOTT | Director | M | Restricted Stock Units | 2248 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 20, 2024 | Conroy Kevin T | President and CEO | M | Common Stock | 10374 | $0.00 | 1,327,844.0000 | 0 | 0.79% | 0.00% |
| Feb. 21, 2024 | Conroy Kevin T | President and CEO | S | Common Stock | 4975 | $61.50 | 1,322,869.0000 | 0 | 0.37% | 0.00% |
| Feb. 20, 2024 | Conroy Kevin T | President and CEO | M | Restricted Stock Units | 10374 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 20, 2024 | Condella Sarah | EVP, Human Resources | M | Common Stock | 2248 | $0.00 | 78,463.0000 | 0 | 2.95% | 0.00% |
| Feb. 21, 2024 | Condella Sarah | EVP, Human Resources | S | Common Stock | 1079 | $61.50 | 77,384.0000 | 0 | 1.38% | 0.00% |
| Feb. 20, 2024 | Condella Sarah | EVP, Human Resources | M | Restricted Stock Units | 2248 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 20, 2024 | Baranick Brian | Gen. Mgr., Precision Oncology | M | Common Stock | 1729 | $0.00 | 10,175.0000 | 0 | 20.47% | 0.00% |
| Feb. 21, 2024 | Baranick Brian | Gen. Mgr., Precision Oncology | S | Common Stock | 895 | $61.50 | 9,280.0000 | 0 | 8.80% | 0.00% |
| Feb. 20, 2024 | Baranick Brian | Gen. Mgr., Precision Oncology | M | Restricted Stock Units | 1729 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 14, 2024 | Conroy Kevin T | President and CEO | M | Restricted Stock Units | 31133 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 14, 2024 | ORVILLE JACOB A | General Manager, Screening | M | Common Stock | 2031 | $0.00 | 9,269.0000 | 0 | 28.06% | 0.00% |
| Feb. 15, 2024 | ORVILLE JACOB A | General Manager, Screening | S | Common Stock | 966 | $61.43 | 8,303.0000 | 0 | 10.42% | 0.00% |
| Feb. 14, 2024 | ORVILLE JACOB A | General Manager, Screening | M | Restricted Stock Units | 2031 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 31, 2023 | Herriott James | General Counsel | A | Common Stock | 68 | $30.02 | 6,913.0000 | 0 | 0.99% | 0.00% |
| Feb. 14, 2024 | Herriott James | General Counsel | M | Common Stock | 883 | $0.00 | 7,796.0000 | 0 | 12.77% | 0.00% |
| Feb. 15, 2024 | Herriott James | General Counsel | S | Common Stock | 421 | $61.43 | 7,375.0000 | 0 | 5.40% | 0.00% |
| Feb. 14, 2024 | Herriott James | General Counsel | M | Restricted Stock Units | 883 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2023 | Conroy Kevin T | President and CEO | A | Common Stock | 709 | $30.02 | 1,300,804.0000 | 0 | 0.05% | 0.00% |
| Feb. 14, 2024 | Elliott Jeffrey Thomas | Chief Financial Officer | M | Common Stock | 3972 | $0.00 | 5,285.0000 | 0 | 302.51% | 0.00% |
| Feb. 15, 2024 | Elliott Jeffrey Thomas | Chief Financial Officer | S | Common Stock | 1888 | $61.43 | 3,397.0000 | 0 | 35.72% | 0.00% |
| Feb. 14, 2024 | Conroy Kevin T | President and CEO | M | Common Stock | 31133 | $0.00 | 1,331,937.0000 | 0 | 2.39% | 0.00% |
| Feb. 14, 2024 | Elliott Jeffrey Thomas | Chief Financial Officer | M | Restricted Stock Units | 3972 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 14, 2024 | COWARD D SCOTT | Director | M | Common Stock | 3972 | $0.00 | 47,650.0000 | 0 | 9.09% | 0.00% |
| Feb. 15, 2024 | COWARD D SCOTT | Director | S | Common Stock | 1376 | $61.43 | 46,274.0000 | 0 | 2.89% | 0.00% |
| Feb. 14, 2024 | COWARD D SCOTT | Director | M | Restricted Stock Units | 3972 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 14, 2024 | Condella Sarah | EVP, Human Resources | M | Common Stock | 2031 | $0.00 | 76,879.0000 | 0 | 2.71% | 0.00% |
| Feb. 15, 2024 | Conroy Kevin T | President and CEO | S | Common Stock | 14791 | $61.43 | 1,317,146.0000 | 0 | 1.11% | 0.00% |
| Feb. 14, 2024 | Condella Sarah | EVP, Human Resources | M | Restricted Stock Units | 2031 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 15, 2024 | Condella Sarah | EVP, Human Resources | S | Common Stock | 965 | $61.43 | 75,914.0000 | 0 | 1.26% | 0.00% |
| Jan. 2, 2024 | Baranick Brian | Gen. Mgr., Precision Oncology | S | Common Stock | 879 | $73.50 | 8,290.0000 | 0 | 9.59% | 0.00% |
| Jan. 2, 2024 | Condella Sarah | EVP, Human Resources | S | Common Stock | 2000 | $73.50 | 74,848.0000 | 0 | 2.60% | 0.00% |